|
Ionis Pharmaceuticals Inc (NASDAQ: IONS) |
|
Ionis Pharmaceuticals Inc
IONS's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Ionis Pharmaceuticals Inc 's sales fell
by -33.08 % in I. Quarter 2024 from the same quarter a year ago.
Ranking at No. 2949
Major Pharmaceutical Preparations industry recorded
growth of revenues by 0.34 %
Ionis Pharmaceuticals Inc net loss increased from $-17 millions, to $-143 millions in I. Quarter 2024,
• More on IONS's Growth
|
|
Ionis Pharmaceuticals Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 69.84 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 6.54.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.22.
• More on IONS's Valuation
|
|
|
|
|
Ionis Pharmaceuticals Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 69.84 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 6.54.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.22.
Ionis Pharmaceuticals Inc Price to Book Ratio is at 17.06 lower than Industry Avg. of 431.3. and higher than S&P 500 Avg. of 0.01
• More on IONS's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com